InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,592.18
(
-0.60%
)
US TECH 100
18,661.60
(
-2.14%
)
Dow Jones
41,091.42
(
-0.39%
)
Brent Oil
77.43
(
-1.98%
)
Bitcoin
58,985.13
(
-0.86%
)
Post# of 15819
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Tommy

Send PM Follow Ignore
Followers 115
Posts 5669
Boards Moderated 7
Alias Born 08/03/2000

Tommy

Member Level

Re: Tommy post# 654

Thursday, 04/12/2012 2:14:39 PM

Thursday, April 12, 2012 2:14:39 PM

Post# of 15819
OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV

http://finance.yahoo.com/news/opko-health-announces-start-phase-154600134.html

Today is a Good Day to Trade - Good Fortune and Happy Trails -
Tommy

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent OPK News
More OPK News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Appoints Warren Levy to Board of Directors • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM

Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!